Cellivery Therapeutics Inc. (268600)
Market Closed
23 Mar, 06:30
KRX SM KRX SM Primary ₩
6,680. 00
0
0%
₩
594.93M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
₩ 6,680
Previous Close Want to track 268600 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cellivery Therapeutics Inc. (268600) Statistics
Valuation metrics
Market Cap 594.93M
Enterprise value 293.14B
Trailing P/E (ttm) -7.51
Forward P/E -
PEG ratio -0.06
Price/Sales (ttm) 13.17
Price/Book (mrq) -10
Enterprise Value/Revenue 15.54
Enterprise Value/EBITDA -12.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 6,680
52-Week high 20,900
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 25 Jul 2022
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.73%
Operating margin -1.04%
Operational effectiveness
Return on assets -1.08%
Return on equity 4.73%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 514.85
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -889
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 39.81
Total debt (mrq) -
Total Debt/Equity (mrq) -1.89
Current ratio (mrq) 0.14%
Book value per share (mrq) -714.23
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
